About
Boomerang Medical is a women-led clinical-stage bioelectronic medicine company based in Silicon Valley, California. The company focuses on innovating treatments for autoimmune diseases, particularly Inflammatory Bowel Disease (IBD) such as Crohn’s disease and ulcerative colitis. They develop a bioelectric neuromodulation technology that uses mild electrical impulses to peripheral nerves to help reduce inflammation associated with these conditions. This technology has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) and is currently being evaluated in clinical trials at leading IBD centers across the United States. The company is committed to improving treatment for autoimmune diseases by leveraging the body's nervous system to manage inflammation. Boomerang Medical is also involved in promoting IBD awareness and education, and they are a member of the Crohn’s & Colitis Foundation’s Corporate Circle. Their clinical trials are designed to generate evidence for their novel therapy, enrolling patients with Crohn’s disease and ulcerative colitis, including those who have previously undergone biologic therapy.
Keywords
Company Information
-
Employees 14
-
Founded 2021
-
Total Funding $15000000
Location
2495 Hospital Dr, Mountain View, California, United States, 94040-4100
